STOCK TITAN
  1. Home
  2. Sec-filings
  3. BIAF
  4. [ARS] bioAffinity Technologies, Inc. SEC Filing

[ARS] bioAffinity Technologies, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - bioAffinity Technologies, Inc.

ARS Filing - bioAffinity Technologies, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: bioAffinity Technologies, Inc. (BIAF)

Acceptance Date: 2026-03-16T17:26:12.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

bioAffinity Tech

NASDAQ:BIAF

View BIAF Stock Overview →

BIAF Rankings

#6415 Ranked by Market Cap
N/A Ranked by Dividends

BIAF Latest News

Mar 13, 2026
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
Mar 10, 2026
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
Mar 3, 2026
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients
Feb 25, 2026
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test
Feb 19, 2026
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

BIAF Latest SEC Filings

Mar 16, 2026
[DEF 14A] bioAffinity Technologies, Inc. Definitive Proxy Statement
Mar 13, 2026
[10-K] bioAffinity Technologies, Inc. Files Annual Report
Mar 13, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event
Mar 10, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event
Mar 6, 2026
[8-K] bioAffinity Technologies, Inc. Reports Material Event

BIAF Stock Data

9.54M
4.36M
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
SAN ANTONIO